Search results for "Radiosensitizing Agent"

showing 1 items of 1 documents

Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines

2017

Background Radioresistance is a common feature of head and neck squamous cell carcinoma (HNSCC). We previously showed that the irradiation- activated vascular endothelial growth factor (VEGF)-extracellular signal-regulated kinase (ERK)-axis is fundamental for the survival of resistant tumors. In this study, we examined if treatment with potent multikinase (MK) inhibitors, sorafenib and sunitinib, could radiosensitize tumor cells. Methods Cultured HNSCC cell lines were treated with inhibitors and subsequently irradiated. Radiosensitizing effects were functionally assessed by annexin-V apoptosis and clonogenic assays and confirmed by Western blot. Additionally, we surveyed human HNSCC tissue …

0301 basic medicineSorafenibMAPK/ERK pathwaySunitinibbusiness.industrymedicine.diseaseHead and neck squamous-cell carcinomaVascular endothelial growth factor03 medical and health scienceschemistry.chemical_compound030104 developmental biology0302 clinical medicineOtorhinolaryngologychemistry030220 oncology & carcinogenesisRadioresistancemedicineCancer researchRadiosensitizing AgentClonogenic assaybusinessmedicine.drugHead & Neck
researchProduct